Results 281 to 290 of about 40,710 (290)

Pleiotropic roles of FXR in liver and colorectal cancers

Molecular and Cellular Endocrinology, 2022
Mingjie Fan, Wendong Huang
exaly  

FXR Agonists as Therapy for Liver Disease

Hepatology, 2020
openaire   +2 more sources

FXR Deficiency Causes Reduced Atherosclerosis in Ldlr −/− Mice

Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
Yanqiao Zhang, Aldons J Lusis
exaly  

Positive regulation of osteogenesis by bile acid through FXR

Journal of Bone and Mineral Research, 2013
Sun Wook Cho, Hyung Jin Choi, Sang Wan Kim   +2 more
exaly  

16 A Dark Side of FXR Activation in Cholestasis. FXR Is a Negative Regulator of MRP4

Gastroenterology, 2009
Barbara Renga, Marco Migliorati, Andrea Mencarelli, Eleonora Distrutti, Stefano Fiorucci   +4 more
openaire   +1 more source

Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism

Molecular Metabolism, 2015
Jorge C Correia, Julie Massart, Jan Freark De Boer   +2 more
exaly  

Transient impairment of the adaptive response to fasting in FXR-deficient mice

FEBS Letters, 2005
Bertrand Cariou, Aldo Grefhorst, Emmanuel Bouchaert   +2 more
exaly  

FXR an emerging therapeutic target for the treatment of atherosclerosis

Journal of Cellular and Molecular Medicine, 2010
Andrea Mencarelli, Stefano Fiorucci
exaly  

Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal

Liver International, 2015
Johannes Schmitt, Bo Kong, Bruno Stieger   +2 more
exaly  

Farnesoid X Receptor (FXR)

2008
openaire   +1 more source